BiotechTube

Ibudilast + Placebo

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pneumonia, Viral

Conditions

Pneumonia, Viral

Trial Timeline

Jan 11, 2021 → Aug 7, 2024

NCT ID
NCT04429555

About Ibudilast + Placebo

Ibudilast + Placebo is a phase 2 stage product being developed by MediciNova for Pneumonia, Viral. The current trial status is completed. This product is registered under clinical trial identifier NCT04429555. Target conditions include Pneumonia, Viral.

What happened to similar drugs?

20 of 20 similar drugs in Pneumonia, Viral were approved

Approved (20) Terminated (4) Active (0)
✅doripenemJohnson & JohnsonApproved
✅Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®MerckApproved
✅Imipenem + ImipenemMerckApproved
✅Ceftolozane / Tazobactam InjectionMerckApproved
✅ceftriaxoneRocheApproved
✅Zavicefta, Ceftazidime-AvibactamPfizerApproved
✅Vancomycin + LinezolidPfizerApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04429555Phase 2Completed

Competing Products

20 competing products in Pneumonia, Viral

See all competitors
ProductCompanyStageHype Score
CAL02 Low-dose + CAL02 High-dose + PlaceboCombioxinPhase 1
19
tacrolimusAstellas PharmaPre-clinical
26
Cefiderocol + Best Available TherapyShionogiPhase 3
40
Cefiderocol + Meropenem + LinezolidShionogiPhase 3
40
Cefiderocol + Standard of Care AntibioticShionogiPhase 1
21
ONO-5046Na + ONO-5046NaOno PharmaceuticalPhase 2
35
doripenemJohnson & JohnsonApproved
43
levofloxacin; imipenem/cilastitinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 2/3
38
LevofloxacinJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
HRS-8427 + MeropenemJiangsu Hengrui MedicinePhase 2
42
Ceftazidime-avibactamAbbViePhase 1
21
Ticagrelor + PlaceboAstraZenecaPhase 2
27
Tedizolid phosphate + LinezolidMerckPhase 3
40
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32